1. Home
  2. VIR vs MLKN Comparison

VIR vs MLKN Comparison

Compare VIR & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.40

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$15.03

Market Cap

1.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
MLKN
Founded
2016
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
VIR
MLKN
Price
$8.40
$15.03
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.63
N/A
AVG Volume (30 Days)
3.5M
669.8K
Earning Date
05-06-2026
03-25-2026
Dividend Yield
N/A
4.99%
EPS Growth
17.49
N/A
EPS
N/A
0.64
Revenue
$68,556,000.00
$3,669,900,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
$1,049.62
$4.79
P/E Ratio
N/A
$23.52
Revenue Growth
N/A
1.14
52 Week Low
$4.16
$13.77
52 Week High
$10.91
$23.18

Technical Indicators

Market Signals
Indicator
VIR
MLKN
Relative Strength Index (RSI) 45.05 23.85
Support Level $5.14 $13.77
Resistance Level $10.29 $16.19
Average True Range (ATR) 0.47 0.61
MACD -0.18 -0.32
Stochastic Oscillator 3.20 14.68

Price Performance

Historical Comparison
VIR
MLKN

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

Share on Social Networks: